Home / Companies / Inzen Therapeutics Inc / Trends
Inzen Therapeutics Inc H-1B trends
Quarterly LCA aggregate trend points for Inzen Therapeutics Inc. Each point carries filing counts, distinct employers, distinct role titles, SOC coverage, wage metrics, certification counts, and source IDs when returned.
Summary
H-1B LCA filings for Inzen Therapeutics Inc span 2020 Q1 to 2022 Q3, peaking at 4 filings in 2022 Q3.
The most recent reported period (2022 Q3) shows 4 filings.
LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
| Period | LCA count | Role titles | SOC codes | Avg wage low | Avg prevailing | Certified | Certification rate |
|---|---|---|---|---|---|---|---|
| 2020 Q1 | 1 | 1 | 1 | $110,000 | $92,352 | 1 | 100.0% |
| 2020 Q3 | 1 | 1 | 1 | $114,000 | $113,714 | 1 | 100.0% |
| 2022 Q3 | 4 | 3 | 3 | $107,250 | $93,818 | 4 | 100.0% |
Frequently asked questions
- How have H-1B filings for Inzen Therapeutics Inc changed over time?
- H-1B LCA filings for Inzen Therapeutics Inc span 2020 Q1 to 2022 Q3, peaking at 4 filings in 2022 Q3. The most recent reported period (2022 Q3) shows 4 filings. LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
Get this page with API
Rendered from the bluedoor H-1B Jobs API. Reproduce it:
GET https://api.bluedoor.sh/h1b-jobs/v1/trends?company=inzen+therapeutics+inc&metric=lca_countJSON